Prostate cancer prevention clinic for men with inherited risk
Part of Cancer, Kidney & urinary clinical trials.
This trial offers a special clinic to help prevent prostate cancer for men who have a higher risk because of their family history or a BRCA gene change. You'll get regular check-ups and guidance to catch any problems early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man and you have a strong family history of prostate cancer, meaning two or more close relatives (like father, brothers, or sons) diagnosed at any age, or at least one close relative diagnosed before age 60.
- You have been tested and found to carry a BRCA1 or BRCA2 gene mutation — a genetic change that can increase cancer risk.
- You may also join if you already have prostate cancer and also have this family history or BRCA mutation.
- You must be at least 18 years old and willing to give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This study tries to personalize prostate cancer care by matching treatment decisions to a person’s specific risk profile. You might be able to join if you have certain types of prostate cancer or a strong family history and meet health-function requirements.
This study looks at your personal and family risk for prostate cancer and helps decide who should have extra screening like MRI. It may help you find cancer earlier if you are at higher genetic risk.
This trial studies how well “active surveillance” works for men with prostate cancer who are considered higher risk because of family history or genetics. It aims to safely monitor the cancer and decide the best timing for treatment if needed, while tracking side effects and follow-up success.
This trial looks for specific DNA repair changes in men with prostate cancer. It tests if these genetic features can help guide treatment decisions. You may join if you have high-risk localized, newly metastatic, or advanced prostate cancer and have tissue available for testing.
This is a study that looks at how prostate cancer runs in families and what genetic factors may be involved. It may help researchers better understand hereditary risk, whether you have prostate cancer or are a family member without it.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.